Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival.

Introduction: The COVID-19 pandemic has delayed medical consultation, possibly leading to the diagnosis of gastrointestinal cancer. The aim of the study was to analyze the impact of SARS-Cov-2 pandemic on new diagnosis and short-term survival of patients with pancreatic cancer (PC).

Methods: All consecutive patients who had a suspected diagnosis of pancreatic lesion before (from March to September 2019) and during COVID 19 pandemic (from March to September 2020).

Malignant deciduoid mesothelioma - to what extent is EUS useful?

An 83-year-old female presented with progressive dyspnea, a non-productive cough and right pleural effusion consistent with exudate. Rapid staining and PCR for mycobacteria, culture and cytology were negative. A thoracic computed tomography (CT) scan revealed a solid lesion, 53 mm in diameter, with an epicenter in the right crus of the diaphragm, both diaphragmatic and hepatic infiltration and compression of the inferior vena cava.

Readmissions due to acute biliary edematous pancreatitis in patients without cholecystectomy.

Aims: Analyzing the readmission of patients with acute biliary edematous pancreatitis (ABEP) without cholecystectomy despite a previous episode of mild acute gallstone pancreatitis or lithiasic cholecystitis. Calculating the health costs associated with the non-performance of cholecystectomy.

Material And Methods: Prospective observational study conducted at a tertiary hospital from July to November 2014.

[Irritable Bowel Syndrome; gut microbiota and probiotic therapy].

Irritable bowel syndrome (IBS) is characterized by symptoms of abdominal pain and altered bowel habits. This common disorder is managed by varying clinical styles as no dominant therapeutic strategy has emerged. The pathophysiology of IBS remains unknown, but several lines of evidence link this disorder with the gut microbiota.